AzTrials
AzTrials

Exercise OncologySPAACESNCT06359210

Sustaining Physical Activity After Cancer Exercise Sessions

A study testing Responder Monthly Behavior Change Discussion Sessions, Incomplete Responder Monthly Behavior Change Discussion Sessions and Incomplete Responder Monthly Behavior Change Discussion Sessions + Bi-Weekly Exercise Sessions in people with Exercise Oncology and Physical Activity Behavior, run by Colorado State University at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to develop and test an adaptive physical activity (PA) maintenance intervention for cancer survivors, after participating in a community-based exercise oncology program. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Responder Monthly Behavior Change Discussion Sessions, Incomplete Responder Monthly Behavior Change Discussion Sessions and Incomplete Responder Monthly Behavior Change Discussion Sessions + Bi-Weekly Exercise Sessions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
105 participants
Where
3 sitesUnited States
Study dates
4 Mar 2024to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ≥18 years old,
  • Able to speak/read English,
  • Diagnosed with any type of cancer,
  • Completed primary or adjuvant treatment (i.e., chemotherapy, radiation therapy, surgery) within the previous five years, with no planned treatment within the next nine months. This does not include long-term or chronic therapies such as anti-hormone or targeted therapies (e.g., aromatase inhibitor, androgen deprivation therapy),
  • Participant is registered/enrolled to participate in one of three community-based exercise programs.

Who cannot join

  • Existing participation in ≥90 minutes per week of at least moderate intensity aerobic exercise AND two or more days per week of resistance exercise or known contraindications for exercise.
  • Known contraindications for non-medically supervised moderate or greater intensity exercise (e.g., uncontrolled hypertension, inability to walk without an assistive device)
  • Current or planned participation in another exercise oncology program (not one of the three community partner exercise programs), or previous participation in another or one of the three community partner exercise programs in the past 12-months.

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Heather Leach, PhD contact

970-491-8951

heather.leach@colostate.edu

Elena Lancioni, MPH contact

970-425-6535

elena.lancioni@colostate.edu

United States3 sites, 1 recruiting
  • Anschutz Medical Center

    Aurora, Colorado, 80045

    Ryan Marker, PhD, PT, (720) 848-0300, ryan.marker@cuanschutz.edu

    Ryan Marker, PhD, PT

    Recruiting
  • Colorado State University

    Fort Collins, Colorado, 80526

    Active, not recruiting
  • University of Wyoming

    Laramie, Wyoming, 82072

    Completed

Other trials in United States

About this study

Official title: An Adaptive Physical Activity Maintenance Intervention

The goal of this clinical trial is to develop and test an adaptive physical activity (PA) maintenance intervention for cancer survivors, after participating in a community-based exercise oncology program. The main questions it aims to answer are:

  • Aim 1: Examine the feasibility and acceptability of the intervention among cancer survivors and community partners. The researchers will utilize quantitative surveys, focus groups, and semi-structured interviews to collect information about feasibility, implementation, adaptation, and sustainability.
  • Aim 2: Examine the effects of the intervention among cancer survivors. The researchers will compare the proportion of participants achieving the exercise guidelines for cancer survivors six-months following completion of the initial exercise program.

Participants will participate in a community-based exercise oncology program and then return to three months of free living. Based on the PA measured at the three-month follow-up, participants will be categorized as a "Responder" or "Incomplete Responder", and then randomized to the PA maintenance intervention. Researchers will compare those that are classified as Responders (meeting exercise guidelines for cancer survivors) and Incomplete Responders (not meeting guidelines for cancer survivors) to see what level of intervention is needed to influence sustainable behavior change in this population.

Read the detailed description

Structured leisure-time physical activity (PA) (i.e., aerobic and resistance exercise) is effective for improving multiple health outcomes related to a cancer diagnosis and cancer treatment and may reduce cancer-specific mortality by as much as 40%. Thus, if cancer survivors can achieve and maintain recommended exercise levels, the public health impact would be substantial.

Supervised exercise interventions that include theory-based behavior change strategies are effective for facilitating increases in moderate to vigorous, leisure-time PA among cancer survivors. However, few studies have focused on maintaining exercise or PA levels following completion of an intervention, and evidence regarding how exercise interventions for cancer survivors can be expanded to clinic or community practice is only now emerging. To achieve the physical, psychosocial, and survival benefits of exercise, survivors must be able to maintain PA long-term, and to support PA maintenance, a socio-ecological approach is necessary. Our approach is informed by theoretical frameworks including social cognitive theory and group dynamics, which will guide intrapersonal and interpersonal level intervention strategies. Integrated research-practice partnership models will guide strategies to address organizational and community-level influences.

The goal is to develop and test an adaptive randomized trial to enhance PA maintenance among cancer survivors. Our central hypothesis is that participants who have difficulty maintaining PA following a community-based exercise program will benefit from additional support in the form of bi-weekly exercise sessions and/or PA behavior change discussion sessions. Our long-term goal is to develop an evidence-based 'stepped' PA maintenance intervention for cancer survivors that can be disseminated to existing community-based cancer-exercise programs nationwide. In the proposed study, cancer survivors will participate in an existing, cancer-specific exercise program at a community-based facility.

All programs will consist of group-based, supervised, instructor-led aerobic and resistance exercise sessions 2x per week, and three PA behavior change discussion sessions. Upon completion of the program, participants will be encouraged to maintain PA levels during a three-month free-living period, during which time there will be no active intervention. After this follow-up period, PA will be measured, and based on PA response (i.e., achieving exercise guidelines for cancer survivors), participants will be randomized to a 3-month, stepped, PA maintenance intervention. The primary outcome of PA maintenance will be assessed six-months after completion of the initial exercise program.

Being tested
Responder Monthly Behavior Change Discussion Sessions, Incomplete Responder Monthly Behavior Change Discussion Sessions, Incomplete Responder Monthly Behavior Change Discussion Sessions + Bi-Weekly Exercise Sessions
Keywords
exercise oncology, physical activity, behavior change, adaptive intervention, cancer survivors, physical activity maintenance, community partnerships
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Responder Monthly Behavior Change Discussion SessionsBehavioural

    Monthly behavior change discussion sessions (3 total) for 12 weeks.

  • Incomplete Responder Monthly Behavior Change Discussion SessionsBehavioural

    Monthly behavior change discussion sessions (3 total) for 12 weeks.

  • Incomplete Responder Monthly Behavior Change Discussion Sessions + Bi-Weekly Exercise SessionsBehavioural

    Monthly behavior change discussion sessions (3 total) for 12 weeks and attend bi-weekly (every other week) exercise classes that mirror the exercises completed in their respective community-based exercise program.

Study groups in NCT06359210
Study groupRoleWhat they receive
Group A- Complete ResponderNo interventionParticipant is randomized to the no further intervention group.
Group B- Complete ResponderExperimentalParticipant is randomized to receive monthly physical activity behavior change discussion sessions for 3-months (total of three sessions).
Receives: Behavioral: Responder Monthly Behavior Change Discussion Sessions
Group C- Incomplete ResponderExperimentalParticipant is randomized to receive monthly physical activity behavior change discussion sessions for 3-months (total of three sessions).
Receives: Behavioral: Incomplete Responder Monthly Behavior Change Discussion Sessions
Group D- Incomplete ResponderExperimentalParticipant is randomized to receive monthly physical activity behavior change discussion sessions for 3-months (total of three sessions) AND bi-weekly exercise sessions (total of six sessions).
Receives: Behavioral: Incomplete Responder Monthly Behavior Change Discussion Sessions + Bi-Weekly Exercise Sessions

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physical Activity program

    Examine the number of participants achieving the exercise guidelines for cancer survivors defined as moderate-intensity aerobic training at least three times per week, for at least 30 minutes, and resistance training at least two times per week. Aerobic exercise will be measured with an accelerometer (continuous bouts of ≥5 minutes of activity at ≥3 METs) and resistance exercise will be measured with a self-report questionnaire (duration and frequency). The measures will be aggregated to determine total amount of physical activity and whether this amount meets or exceeds the recommended guidelines.

    Measured: Measured at baseline, after completion of the exercise program (either 8-weeks or 12-weeks), 3-months post program, and 6-months post program

Secondary outcomes (3)
  1. Quality of Life (QOL)

    Measured using the Functional Assessment of Cancer Therapy-General (FACT-G), a quantitative, self-report measure of QOL. The FACT-G is a 27-item self-report measure, with subscales evaluating physical, social, emotional, and functional well-being. FACT-G scores range from 0 to 108, with higher total and subscale scores indicating better QOL.

    Measured: Measured at baseline, after completion of the exercise program (either 8-weeks or 12-weeks), 3-months post program, and 6-months post program

  2. Physical Fitness - Aerobic

    Aerobic fitness will be assessed with either a submaximal, graded exercise test on a motorized, calibrated treadmill, or the two minute step test.

    Measured: Measured at baseline, after completion of the exercise program (either 8-weeks or 12-weeks), 3-months post program, and 6-months post program

  3. Physical Fitness - muscular strength and endurance

    Muscular strength and endurance will be assessed by the number of full stands from a chair, and the number of bicep curls (holding a hand weight of 5lbs) that can be completed in 30 seconds.

    Measured: Measured at baseline, after completion of the exercise program (either 8-weeks or 12-weeks), 3-months post program, and 6-months post program

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Apr 2024
  2. Study start4 Mar 2024
  3. Primary completion1 May 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Sequential
Model description
An adaptive design results in a final total of 4 possible subgroups, depending upon responder/non-responder status, and researchers plan to compare the proportion of participants achieving the minimum exercise guidelines for cancer survivors within the responders and incomplete responder subgroups. Admittedly however, it is not possible to fully elucidate the analyses the researchers will conduct, as researchers cannot predict the number of subgroups that participants will represent at the end of the trial (e.g., if there are no "incomplete responders" the design reduces to randomization to only two groups), nor the number of participants who will be in those subgroups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
105 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06359210
Sponsor's protocol ID
4973
Other IDs
4R33CA256656-03
Acronym
SPAACES
Status last verified
Mar 2026
First submitted
20 Mar 2024
Last updated
19 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Responder Monthly Behavior Change Discussion Sessions, Incomplete Responder Monthly Behavior Change Discussion Sessions and Incomplete Responder Monthly Behavior Change Discussion Sessions + Bi-Weekly Exercise Sessions in people with Exercise Oncology and Physical Activity Behavior, run by Colorado State University at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Heather Leach, PhD (970-491-8951, heather.leach@colostate.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physical Activity program (time frame: Measured at baseline, after completion of the exercise program (either 8-weeks or 12-weeks), 3-months post program, and 6-months post program). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2026; AzTrials last refreshed its copy on 29 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in